Viatris Inc. ( VTRS) - Stock Earnings
VTRS Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Aug. 6, 2026, midnight | — / — | — | — / — | — |
VTRS Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q3 | -128.2 million USD | 3.8 billion USD |
| 2025Q4 | -340.1 million USD | 3.7 billion USD |
| 2026Q1 | 176.4 million USD | 3.5 billion USD |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
VTRS Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | 54.7 million USD | 15.4 billion USD |
| 2024 | -634.2 million USD | 14.7 billion USD |
| 2025 | -3.5 billion USD | 14.3 billion USD |
| 2026 Est. | — | — |
VTRS
Price: $17.32
Dividend Yield: 2.87%
Forward Dividend Yield: 2.78%
Payout Ratio: -88.89%
Dividend Per Share: 0.48 USD
Earnings Per Share: -0.30 USD
Exchange: NMS
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Country: United States
Volume: 6.2 million
Market Capitalization: 19.4 billion
Average Dividend Frequency: 4
Years Paying Dividends: 6
DGR3: 1.45%